Are the COVID-vaccines cause of cerebral vascular accident (CVA) and others pathologies? DOI Open Access
Cristela Moreno García

International Journal of Molecular Biology Open Access, Год журнала: 2024, Номер 7(1), С. 73 - 76

Опубликована: Май 20, 2024

to the protection of public health from disease-causing pathogens.A vaccine A is a substance that acts as stimulator immune system so it can better protect itself viruses and other infectious agents.In 19th century, French doctor Louis Pasteur developed second generation vaccines, among others against cholera or rabies, introduced term in honor Jenner's experiments with cows.Table 1 Many influencers claim COVID vaccines have led side effects adverse reactions such disorders, headaches, heart attacks over past year.But do we any reason believe these claims?Why has trust waned last four years since pandemic began?©2024 García.

Язык: Английский

Long COVID and Wavering Incidence of Pulmonary Embolism: A Systematic Review DOI Creative Commons
Bushra Shah,

Mah Noor Ahmad,

Musfira Khalid

и другие.

Journal of Community Hospital Internal Medicine Perspectives, Год журнала: 2023, Номер 13(5)

Опубликована: Сен. 2, 2023

Pulmonary embolism (PE) is a serious medical condition that can occur as result of venous thromboembolism (VTE). COVID-19, also known Post-Acute Sequelae SARS-CoV-2 infection (PASC), potentially lead to PE due the formation blood clots in lungs. This study aims collate and report trends patients with long COVID (4-12 weeks since infection) post-COVID-19 syndrome (>12 infection). The adhered PRISMA Statement 2020 guidelines, systematic search was conducted four databases. In total, nine observational studies were included total patient count 45,825,187. incidence COVID/post-COVID-19 seen among 31,885 individuals out 44,967,887 participants. rate observed 0.07%, given matched controls. While we cannot state certainty COVID-19 itself leads higher risks at later time, this emphasizes need for optimized care longitudinal during era account deviations from norm.

Язык: Английский

Процитировано

8

Immune landscape and redox imbalance during neurological disorders in COVID-19 DOI Creative Commons
Abhimanyu Thakur, Vartika Sharma, Sera Averbek

и другие.

Cell Death and Disease, Год журнала: 2023, Номер 14(9)

Опубликована: Сен. 6, 2023

The outbreak of Coronavirus Disease 2019 (COVID-19) has prompted the scientific community to explore potential treatments or vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), virus that causes illness. While SARS-CoV-2 is mostly considered a pathogen, several neurological complications have been reported, raising questions about how it may enter Central Nervous System (CNS). Receptors such as ACE2, CD147, TMPRSS2, and NRP1 identified in brain cells be involved facilitating entry into CNS. Moreover, proteins like P2X7 Panx-1 contribute pathogenesis COVID-19. Additionally, role immune system gravity COVID-19 investigated with respect both innate adaptive responses caused by infection, which can lead cytokine storm, tissue damage, manifestations. A redox imbalance also linked COVID-19, potentially causing mitochondrial dysfunction, generating proinflammatory cytokines. This review summarizes different mechanisms reactive oxygen species neuro-inflammation development recent progress study immunological events bioinformatics implications

Язык: Английский

Процитировано

7

SARS-CoV-2 infection predicts larger infarct volume in patients with acute ischemic stroke DOI Creative Commons
Manuela De Michele, Svetlana Lorenzano, Paola Piscopo

и другие.

Frontiers in Cardiovascular Medicine, Год журнала: 2023, Номер 9

Опубликована: Янв. 10, 2023

Background and purpose Acute ischemic stroke (AIS) is a fearful complication of Coronavirus Disease-2019 (COVID-19). Aims this study were to compare clinical/radiological characteristics, endothelial coagulation dysfunction between acute patients with without COVID-19 investigate if how the SARS-CoV-2 spike protein (SP) was implicated in triggering platelet activation. Methods We enrolled AIS within 12 h from onset compared them an age- sex-matched cohort controls COVID-19. Neuroimaging studies performed 24 h. Blood samples collected subset 10 patients. Results Of 39 patients, 22 had 17 did not. Admission levels Factor VIII von Willebrand factor antigen significantly higher positively correlated infarct volume. In multivariate linear regression analyses, independent predictor volume (B 20.318, Beta 0.576, 95%CI 6.077–34.559; p = 0.011). SP found serum 2 examined Platelets healthy donors showed similar degree procoagulant activation induced by non-COVID-19 patients' sera. The anti-SP anti-FcγRIIA blocking antibodies no effect modulating activity both groups. Conclusions infection seems play major role endothelium extension during AIS.

Язык: Английский

Процитировано

6

Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated? DOI Open Access

Neda Omidian,

Pantea Mohammadi, Mona Sadeghalvad

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2022, Номер 154, С. 113534 - 113534

Опубликована: Авг. 17, 2022

Cerebral microvascular disease has been reported as a central feature of the neurological disorders in patients with SARS-CoV-2 infection that may be associated an increased risk ischemic stroke. The main pathomechanism development cerebrovascular injury due to can consequence endothelial cell dysfunction structural part blood-brain barrier (BBB), which accompanied by inflammatory response and thrombocytopenia along blood coagulation disorders. In this review, we described properties BBB, neurotropism behavior SARS-CoV-2, possible mechanisms damage CNS upon infection.

Язык: Английский

Процитировано

8

COVID-19 and Acute Ischemic Stroke Mortality and Clinical Outcomes among Hospitalized Patients in the United States: Insight from National Inpatient Sample DOI Open Access
Monique G. Davis, Karthik Gangu,

Sajid Suriya

и другие.

Journal of Clinical Medicine, Год журнала: 2023, Номер 12(4), С. 1340 - 1340

Опубликована: Фев. 8, 2023

Coronavirus-19, primarily a respiratory virus, also affects the nervous system. Acute ischemic stroke (AIS) is well-known complication among COVID-19 infections, but large-scale studies evaluating AIS outcomes related to infection remain limited. We used National Inpatient Sample database compare acute patients with and without COVID-19. A total of 329,240 were included in study: (n = 6665, 2.0%) 322,575, 98.0%). The primary outcome was in-hospital mortality. Secondary mechanical ventilation, vasopressor use, thrombectomy, thrombolysis, seizure, venous thromboembolism, myocardial infarction, cardiac arrest, septic shock, kidney injury requiring hemodialysis, length stay, mean hospitalization charge, disposition. who COVID-19-positive had significantly increased mortality compared (16.9% vs. 4.1%, aOR: 2.5 [95% CI 1.7-3.6], p < 0.001). This cohort ventilation injury, charge. Further research regarding vaccination therapies will be vital reducing worse

Язык: Английский

Процитировано

4

Ischemic and Hemorrhagic Cerebrovascular Events Related to COVID-19 Coagulopathy and Hypoxemia DOI Open Access
Michał Sojka, Anna Drelich‐Zbroja, Maryla Kuczyńska

и другие.

International Journal of Environmental Research and Public Health, Год журнала: 2022, Номер 19(18), С. 11823 - 11823

Опубликована: Сен. 19, 2022

Since the very beginning of COVID-19 pandemic, numerous researchers have made an effort to determine molecular composition SARS-CoV-2 virus, and exact pathomechanism through which virus exerts such a devastating effect on host/infected organism. Recent scientific evidence highlights affinity towards ACE2 receptors, are widespread in multiple human systems, including central nervous system (CNS) cerebral vessels. Such may explain endothelial dysfunction damage that is observed COVID-positive patients histopathological studies, with subsequent dysregulation circulation leading transient or acute cerebrovascular accidents. In this paper, we aimed evaluate effects COVID-related hypoxemia direct viral invasion circulation, special respect postulated pathomechanism, vulnerable groups patients, clinical course outcomes, as well diagnostic imaging findings.

Язык: Английский

Процитировано

7

Clinically suspected lethal viral myocarditis combined with encephalitis: a COVID‐19 vaccine complication DOI Creative Commons
Junhui Chen, Ting Wu, Chunlei Zhang

и другие.

ESC Heart Failure, Год журнала: 2022, Номер 10(2), С. 1422 - 1425

Опубликована: Ноя. 8, 2022

This case study aimed to identify rare viral myocarditis combined with encephalitis as a COVID-19 vaccine complication. A 59-year-old male patient 2 day history of headache and rapidly progressive cognitive decline, who had received the third dose 12 days before, was admitted our hospital. The no underlying systemic conditions, prior medical history, infection. diagnosed by two neurologists cardiologists after laboratory examination, head computed tomography, magnetic resonance imaging evaluation. experienced cardiogenic shock developed severe arrhythmia, resulting in his death 10 h admission. Clinically suspected lethal could be related vaccination. Adverse effects Chinese vaccine, especially serious complications, have been uncommon. highlights complication vaccination that needs high attention.

Язык: Английский

Процитировано

5

The Effect of COVID-19 Vaccines on Stroke Outcomes: A Single-Center Study DOI Open Access
Kareem El Naamani, Abdelaziz Amllay, Ching‐Jen Chen

и другие.

World Neurosurgery, Год журнала: 2022, Номер 170, С. e834 - e839

Опубликована: Дек. 7, 2022

Язык: Английский

Процитировано

5

Toxicity of the spike protein of COVID-19 is a redox shift phenomenon: A novel therapeutic approach DOI Open Access

Laurent Schwartz,

Manuel Aparicio-Alonso, Marc Henry

и другие.

Free Radical Biology and Medicine, Год журнала: 2023, Номер 206, С. 106 - 110

Опубликована: Июнь 29, 2023

Язык: Английский

Процитировано

2

Update on Central Nervous System Effects of the Intersection of HIV-1 and SARS-CoV-2 DOI
Ferron F. Ocampo, Pathariya Promsena, Phillip Chan

и другие.

Current HIV/AIDS Reports, Год журнала: 2023, Номер 20(6), С. 345 - 356

Опубликована: Ноя. 11, 2023

Язык: Английский

Процитировано

2